Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05337826 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

Study acronym: REST
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from May 2026 to Sep 2026v6
  2. Primary completion date changed from estimate of Oct 2025 to Nov 11, 2025v5
  3. Trial status: Recruiting to Active, Not Recruitingv4 Show 4 more changesShow less
    • Enrollment target: estimated 120 to confirmed 122
    • Primary completion date: Apr 2025 to Oct 2025
    • Study completion date: May 2025 to May 2026
    • Site details revised at 2 of 2 sites
  4. Primary completion date: Apr 2024 to Apr 2025
    • Study completion date: Oct 2024 to May 2025
    v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2022 to Apr 20, 2022
    • Site details revised at 2 of 2 sites
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixed-methods approach. To assess the impact of REST model on economic factors and quality of life measures. The goal of this study is to facilitate the adoption of continuous glucose monitoring (CGM) in older adults (≥65 years) with diabetes mellitus (DM) on complex insulin regimens, and additionally, to build a framework for sustained CGM use over time using a novel patient-centered model - the REST model.
Trial Details
NCT Number NCT05337826
Lead Sponsor Joslin Diabetes Center
Collaborators: State University of New York - Upstate Medical University, Cecilia Health
Conditions
(from sponsor)		 Diabetes Mellitus
Related terms Diabetes Mellitus
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov